Eurostars Grant of 2.3 Million EUR awarded to Readily3D, CelVivo, Bioneer, SDU, and EPFL: 3D cell-based assays

2024-02-02T13:11:55+00:00

Eurostars Grant of 2.3 Million EUR awarded to Readily3D, CelVivo, Bioneer, SDU, and EPFL: 3D cell-based assays The Swiss and Danish consortium participants will merge their expertise to develop a platform for the automated production of 3D cell-based assays. The simplest cell-based assays are in vitro, 2D monolayer cultures, which lack physiological relevance and functionality, [...]

Eurostars Grant of 2.3 Million EUR awarded to Readily3D, CelVivo, Bioneer, SDU, and EPFL: 3D cell-based assays2024-02-02T13:11:55+00:00

The Innovation Fund invests in the development of CYM-001, an innovative Bispecific Antibody to treat Metastatic castration- resistant Prostate Cancer (BAMPC)

2023-10-23T13:25:24+00:00

The Innovation Fund invests in the development of CYM-001, an innovative Bispecific Antibody to treat Metastatic castration- resistant Prostate Cancer (BAMPC) September 13, 2023 The Innovation Fund has invested approximately DKK 12.3 million in a research project aimed at developing a biological drug candidate that represents a completely new concept in cancer treatment. The [...]

The Innovation Fund invests in the development of CYM-001, an innovative Bispecific Antibody to treat Metastatic castration- resistant Prostate Cancer (BAMPC)2023-10-23T13:25:24+00:00

DigitSTEM – a new, large Danish stem cell research initiative

2023-10-23T13:14:11+00:00

DigitSTEM – a new, large Danish stem cell research initiative in the neurodegenerative and immuno-oncology fields.  DigitSTEM is a four-year stem cell focused research collaboration between The Technical University of Denmark (DTU), University of Copenhagen and Bioneer A/S. The collaborating partners are: DTU Bioengineering, DTU Compute and DTU Health Tech, The Novo Nordisk Foundation [...]

DigitSTEM – a new, large Danish stem cell research initiative2023-10-23T13:14:11+00:00

Strategic collaboration between Bioneer A/S & National Biologics Facility

2021-09-16T12:33:27+00:00

Bioneer A/S announces a strategic collaboration with the National Biologics Facility (NBF) to commercialize their combined CRO services for mammalian expression of recombinant proteins. Copenhagen, September 16th, 2021. Bioneer A/S, a globally operating Danish specialty-CRO creating and commercializing innovative research service solutions for early stage drug development and in vitro modelling, announced today [...]

Strategic collaboration between Bioneer A/S & National Biologics Facility2021-09-16T12:33:27+00:00

Rare Disease training course: Pluripotent stem cells for rare disease research: banking, data, application, October 25-27, 2021

2021-09-07T13:07:46+00:00

Bioneer is happy to announce that we will be participating in the Rare Diseases training course: Pluripotent stem cells for rare disease research: banking, data, application from October 25th to 27th in an online format.  Rare disease (RD) is one area where national and international multidisciplinary collaborations are valuable to overcome some of [...]

Rare Disease training course: Pluripotent stem cells for rare disease research: banking, data, application, October 25-27, 20212021-09-07T13:07:46+00:00

“Signal Transduction at the Blood-Brain Barriers”, Virtual symposium, September 22-24, 2021

2021-09-07T09:11:11+00:00

Bioneer is delighted to participate to the 23rd Symposium "Signal Transduction at the Blood-Brain Barriers", held September 22-24, 2021, as a virtual symposium. The 23rd International Symposium "Signal Transduction at the Blood-Brain Barriers" was originally planned for September 2021 in Bari / Italy, but had to be postponed to September/October 2022. The Scientific [...]

“Signal Transduction at the Blood-Brain Barriers”, Virtual symposium, September 22-24, 20212021-09-07T09:11:11+00:00

Bioneer & COVID-19 projects, collaboration with UNION therapeutics

2021-08-26T11:54:01+00:00

Bioneer supports companies in their quest to help COVID-19 affected people around the world. In 2020, there has been an increase in new research projects to find novel therapeutic and/or preventive treatments for COVID-19 disease. In the Medicon Valley region alone more than 200 COVID-19-related research projects were initiated according to the report ‘State [...]

Bioneer & COVID-19 projects, collaboration with UNION therapeutics2021-08-26T11:54:01+00:00

SelectScience webinar, A new era of RNA detection, June 28, 2021

2021-06-29T13:44:48+00:00

Bioneer is delighted to be a part of SelectScience next webinar on June 28th about a new era of RNA detection. SelectScience is holding a webinar on Monday, June 28th at 17:00, where Bioneer’s expert in Molecular Histology Dr. Boye Schnack Nielsen will present a new era of RNA detection: exploring new technologies and prospects. In [...]

SelectScience webinar, A new era of RNA detection, June 28, 20212021-06-29T13:44:48+00:00

ISSCR 2021 – The Global Stem Cell Event Virtual, June 21, 2021

2021-06-29T13:43:05+00:00

Bioneer is looking forward to participating to the ISSCR 2021, the Global Stem Cell Event Virtual, on June 21st and presenting at the focus session on developments to simplify and accelerate iPSC research with EBiSC. The presentation if part of the Focus Sessions of the ISSCR Annual Meeting, where Dr. Benjamin Schmid and Dr. Mikkel Rasmussen from [...]

ISSCR 2021 – The Global Stem Cell Event Virtual, June 21, 20212021-06-29T13:43:05+00:00

Medicon Valley Alliance’s R&D Network meeting, May 20, 2021

2021-06-29T13:40:52+00:00

Bioneer is looking forward to participating in the next Medicon Valley Alliance’s R&D Network meeting on May 20th about the research infrastructure in the Danish life science cluster. The Medicon Valley Alliance R&D Network is a professional and social network for C-level R&D executives (CSOs, CMOs, VPs), university professors and PIs, and top-level managers in [...]

Medicon Valley Alliance’s R&D Network meeting, May 20, 20212021-06-29T13:40:52+00:00
Go to Top